Co-Diagnostics, Inc. (CODX)

Co-Diagnostics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	38	41	78	258	263	16
Market Cap Growth	-23.50%	-47.80%	-69.80%	-1.85%	1593.67%	-19.33%
Enterprise Value	-9	-15	-3	168	216	15
PE Ratio	-	-1.15	-5.47	7.04	6.19	-2.50
PS Ratio	5.76	5.97	2.28	2.64	3.53	72.21
PB Ratio	0.49	0.47	0.68	1.92	3.94	8.94
P/FCF Ratio	-1.31	-1.73	15.15	6.39	9.60	-2.75
P/OCF Ratio	-1.40	-1.84	11.86	6.28	9.33	-2.81
EV/Sales Ratio	-1.82	-2.19	-0.09	1.72	2.89	68.05
EV/EBITDA Ratio	0.32	0.40	0.18	3.66	5.05	-2.43
EV/EBIT Ratio	0.31	0.39	0.16	3.68	5.06	-2.40
EV/FCF Ratio	0.46	0.63	-0.60	4.16	7.87	-2.59
Debt / Equity Ratio	0.04	0.03	0.00	-	-	-
Debt / EBITDA Ratio	-0.07	-0.08	-0.02	-	-	-
Debt / FCF Ratio	-0.10	-0.13	0.07	-	-	-
Quick Ratio	9.56	10.24	21.89	8.79	14.63	3.12
Current Ratio	10.19	10.81	23.94	9.14	16.69	4.83
Asset Turnover	0.07	0.06	0.23	0.89	1.61	0.05
Interest Coverage	-	-	-	-	-	-57.21
Return on Equity (ROE)	-42.40%	-35.40%	-10.50%	36.80%	97.40%	-160.50%
Return on Assets (ROA)	-38.60%	-32.60%	-9.40%	33.40%	91.80%	-141.90%
Return on Capital (ROIC)	-53.01%	-47.98%	-23.49%	27.52%	62.38%	-339.26%
Earnings Yield	-101.08%	-86.87%	-18.27%	14.21%	16.16%	-39.91%
FCF Yield	-69.30%	-57.65%	6.60%	15.66%	10.42%	-36.32%
Buyback Yield / Dilution	-1.22%	6.77%	-5.27%	-6.80%	-67.10%	-34.22%
Total Shareholder Return	-1.22%	6.77%	-5.27%	-6.80%	-67.10%	-34.22%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).